Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model
Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
Curcumin: New Insights into an Ancient Ingredient against Cancer
Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
Immunotherapy in Ovarian Cancer
Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
Melanoma vaccines: clinical status and immune endpoints
New treatment modalities with vaccine therapy in renal cell carcinoma
Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
[Vaccines for the treatment of non-small cell lung cancer]
Recent Advances in Cancer Stem Cell-Targeted Immunotherapy